Results 231 to 240 of about 1,334,045 (336)

What Is the Value of the Routine Use of Patient-Reported Outcome Measures Toward Improvement of Patient Outcomes, Processes of Care, and Health Service Outcomes in Cancer Care? A Systematic Review of Controlled Trials [PDF]

, 2014
Grigorios Kotronoulas, Nora Kearney, Roma Maguire, Alison Harrow, David Di Domenico, Suzanne Croy, Stephen MacGillivray   +6 more
openalex   +1 more source

Olaparib synergy screen reveals Exemestane induces replication stress in triple‐negative breast cancer

Molecular Oncology, EarlyView.
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh, Liping Su, Suet Lin Chia, Xiaohe Tian, Haslina Ahmad, Martin R. Gill   +5 more
wiley   +1 more source

The benefits of capturing patient-reported outcome measures for treatment of obstructive sleep apnea with hypoglossal nerve stimulation. [PDF]

J Clin Sleep Med
Vanderveken OM.
europepmc   +1 more source

A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity [PDF]

, 2014
Reena Khanna, Guangyong Zou, Geert D’Haens, Brian G. Feagan, William J. Sandborn, Margaret K. Vandervoort, Robert Rolleri, Enoch Bortey, Craig Paterson, William P. Forbes, Barrett G. Levesque   +10 more
openalex   +1 more source

Bioengineering facets of the tumor microenvironment in 3D tumor models: insights into cellular, biophysical and biochemical interactions

FEBS Open Bio, EarlyView.
The tumor microenvironment is a dynamic, multifaceted complex system of interdependent cellular, biochemical, and biophysical components. Three‐dimensional in vitro models of the tumor microenvironment enable a better understanding of these interactions and their impact on cancer progression and therapeutic resistance.
Salma T. Rafik, Deniz Bakkalci, Alexander J. MacRobert, Umber Cheema   +3 more
wiley   +1 more source

Properties of Measurements of Patient-Reported Outcome Measures Physical Activity Assessment in Chronic Kidney Disease: A Systematic Review. [PDF]

Physiother Res Int
Stella TC, Santos IS, Alves da Silva G, Gomes CA, Malosá Sampaio LM.   +4 more
europepmc   +1 more source

An introduction to patient-reported outcome measures (PROMs) in physiotherapy [PDF]

, 2014
Derek Kyte, Melanie Calvert, Philip J. van der Wees, Ruth ten Hove, Stephanie S. Tolan, Jonathan Hill   +5 more
openalex   +1 more source

Long non‐coding RNAs as therapeutic targets in head and neck squamous cell carcinoma and clinical application

FEBS Open Bio, EarlyView.
Long non‐coding RNAs (lncRNAs) occupy an abundant fraction of the eukaryotic transcriptome and an emerging area in cancer research. Regulation by lncRNAs is based on their subcellular localization in HNSCC. This cartoon shows the various functions of lncRNAs in HNSCC discussed in this review.
Ellen T. Tran, Ruchi A. Patel, Amogh Chariyamane, Ratna B. Ray   +3 more
wiley   +1 more source

Using patient-reported outcome measures in clinical trials: perspectives for and against a modular approach. [PDF]

Med J Aust
Ng CA, Roydhouse J, Luckett T, Lourenco RA, Mulhern B.   +4 more
europepmc   +1 more source

Interviewing to develop Patient-Reported Outcome (PRO) measures for clinical research: eliciting patients’ experience [PDF]

, 2014
Anne Brédart, Alexia Marrel, Linda Abetz-Webb, Kathy Lasch, C. Acquadro   +4 more
openalex   +1 more source